Feb 22, 2026 by Neil PatelThe Best Stocks to Invest $50,000 in Right NowInvestors don't have to look any further than these two dominant internet firms.
Feb 22, 2026 by Robert IzquierdoIs Cognex Stock a Buy or Sell After a Director Dumped Shares Worth $128,000?This automation technology leader, known for machine vision systems, reported a notable insider sale amid strong one-year share performance.
Feb 22, 2026 by Maurie BackmanCounting on Home Equity to Fund Your Retirement? Here's Why You Shouldn't.It might seem like a good plan, but it could backfire.
Feb 22, 2026 by Brett SchaferWhere Will Rocket Lab Stock Be in 10 Years?The spaceflight company has shot up like, well, a rocket since its market debut a few years ago.
Feb 22, 2026 by Daniel FoelberPrediction: 3 Stocks That'll Be Worth More Than Walmart 5 Years From NowWalmart has crushed the S&P 500 in recent years, but the red-hot stock is due for a cooldown.
Feb 22, 2026 by Reuben Gregg BrewerNovartis: This Big Pharma Giant Could Be a Sleep‑at‑Night Core Holding for DecadesNovartis has a solid portfolio of drugs and a pipeline that should keep the business humming.
Feb 22, 2026 by Robert IzquierdoJFrog's CTO Sold Shares Worth $2.5 Million. Is the Stock a Buy or Sell?JFrog, a leader in DevOps software solutions, reported a notable insider sale amid ongoing growth in enterprise adoption.
Feb 22, 2026 by Daniel SparksIs CrowdStrike Stock a Buy After Falling 17% Year to Date?CrowdStrike is still growing quickly, but the stock's valuation assumes that pace holds up with little noise.
Feb 22, 2026 by Todd ShriberBetting Against Wall Street: The Inverse ETF Surge No One Is Talking AboutThe ProShares UltraShort Financials ETF ratchets up bearish bets on a popular sector.
Feb 22, 2026 by Micah Zimmerman2 Quantum Computing Stocks That Could Make a MillionaireQuantum computing is still a high-risk frontier, but for patient investors, these two tickers could be tomorrow's generational wealth creators.
Feb 22, 2026 by Jonathan PoncianoPraxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 MillionPraxis Precision Medicines targets neurological and psychiatric disorders with a pipeline of precision therapies for CNS conditions.
Feb 22, 2026 by Jonathan PoncianoCelcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two PositionCelcuity develops targeted cancer therapies and diagnostic platforms, with a focus on advancing precision medicine in oncology.
Feb 22, 2026 by Dave Kovaleski2 Financial Stocks Poised for a Comeback in 2026Both stocks are in the Berkshire Hathaway portfolio, selected by former CEO Warren Buffett.
Feb 22, 2026 by Jonathan PoncianoApogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing ConvictionApogee Therapeutics develops biologic therapies targeting dermatology and respiratory conditions, with lead candidates in clinical trials.
Feb 22, 2026 by James BrumleyMy 5 Favorite Dividend Stocks to Buy Right NowThere are several solid prospects to choose from right now, but there's a reason I can't get these particular names out of my head.
Feb 22, 2026 by Stefon WaltersAre You Really Ready to Start Collecting Social Security? 3 Signs It Might Be the Perfect TimeChecking these boxes can help ease your claiming decision.
Feb 22, 2026 by Jonathan Ponciano$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug EmergesArcellx develops next-generation cell therapies targeting multiple myeloma and other hematologic cancers in the biotechnology sector.
Feb 22, 2026 by Reuben Gregg BrewerLeveraged ETFs Are Among the Market's Most Aggressive Investment Tools. But Should You Avoid Them Altogether?What if you could double or even triple the market's return? Is it worth the risk?
Feb 22, 2026 by Cory RenauerArohi Asset Exits a Big Software Bet by Selling 1.7M DoubleVerify (DV) Shares Worth $20.6 MillionDoubleVerify provides digital media measurement and analytics tools for advertisers and publishers across multiple sectors.
Feb 22, 2026 by Dominic BasultoCould Buying XRP Today Set You Up for Life?Turning a modest upfront investment in XRP into life-changing wealth is harder than it sounds.
